Tag Archives: pharmaceutical mergers

Everyone in the pharmaceutical business is aware of the trend toward ‘consolidation’.  I think this is really a misnomer because typically the companies are not ‘consolidated’ into one continuing organization.  In my experience what happens is that the acquiring company … Continue reading →